Abstract
Get full access to this article
View all access options for this article.
References
1.
O'Brien
E
. Why ABPM should be mandatory in all trials of blood pressure-lowering drugs . Drug Inf J . 2011 ;45 :233 –239 .
2.Tribenzor . Highlights of prescribing information . 2010 . http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/200175s001lbl.pdf.
3.Edarbi . Highlights of prescribing information . 2011 . http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/200796s001lbl.pdf.
4.Center for Drug Evaluation and Research . Valturna medical review . 2009 . http://www.accessdata.fda.gov/drugsatfda_docs/nda/2009/022217s000medr.pdf.
5.Center for Drug Evaluation and Research . Tekturna medical review . 2007 . http://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021985s000_MedR_P1.pdf.